Reflux: When Is It More Than a Laundry Problem?

Area of Science:

• Pediatric Gastroenterology
• Neonatal Care
• Pharmacology

Background:

• Infant reflux is commonly treated with proton-pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs), despite limited evidence supporting routine use.
• Symptoms of physiologic gastroesophageal reflux (GER) can overlap with gastroesophageal reflux disease (GERD) and other conditions like cow's milk protein intolerance.
• Over-prescription of acid suppression therapy in infants is a growing concern in pediatric well-visits.

Purpose of the Study:

• To emphasize the importance of differentiating physiologic GER from GERD in infants.
• To advocate for conservative management strategies before initiating pharmacologic interventions for infant reflux.
• To guide clinicians on appropriate diagnostic and therapeutic approaches for infant reflux.

Main Methods:

• Review of current evidence regarding pharmacologic management of infant reflux.
• Clinical guidance based on distinguishing GER from GERD symptoms.
• Emphasis on thorough patient history and physical examination.

Main Results:

• Cautionary evidence exists against the routine use of PPIs and H2RAs for infant reflux.
• Nonpharmacologic interventions and anticipatory guidance are recommended as first-line approaches.
• Consultation with a pediatric gastroenterologist is advised if medication is considered necessary.

Conclusions:

• Acid suppression therapy should not be the initial treatment for infant reflux.
• Accurate diagnosis and conservative management are key to appropriate infant reflux care.
• Prioritizing nonpharmacologic methods can reduce unnecessary medication exposure in infants.